NEW YORK, Oct. 23, 2023 /PRNewswire/ — The benign prostatic hyperplasia (BPH) devices market size is expected to grow by USD 3.34 billion from 2021 to 2026. In addition, the momentum of the market will progress at a CAGR of 5.09% during the forecast period, according to Technavio Research. The market has been segmented by Geography (North America, Europe, Asia, and Rest of World (ROW)). 37% of the market’s growth originates from North America during the forecast period. The US and Canada are the major countries for benign prostatic hyperplasia (BPH) devices in North America. Factors such as the growing geriatric population, rising incidence of BPH, and perpetual innovations in BPH devices facilitate market growth. This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment. Read a FREE PDF Sample Report
Technavio has announced its latest market research report titled Global Benign Prostatic Hyperplasia (BPH) Devices Market 2022-2026
Company Profile:
Astellas Pharma Inc., biolitec AG, Boston Scientific Corp., Butterfly Medical, Coloplast AS, Convergent Laser Technologies, IPG Photonics Corp., KARL STORZ SE and Co. KG, Medeon Biodesign Inc., Medifocus Inc., Olympus Europa SE and Co. KG, OmniGuide Holdings Inc., ProArc Medical, PROCEPT BioRobotics Corp., Richard Wolf GmbH, SRS Medical, Teleflex Inc., Urologix LLC, Vendor Credentialing Service LLC dba symplr, Zenflow Inc.
Boston Scientific Corp. – The company offers benign prostatic hyperplasia devices such as Rezum Water Vapor Therapy and GreenLight XPS.
• To gain access to more vendor profiles available with Technavio, buy the report!
Benign Prostatic Hyperplasia (BPH) Devices Market: Segmentation Analysis
By therapy, the TURP segment is significant during the forecast period. Many organizations such as the American Urological Association (AMA), the Canadian Urological Association (CUA), and the European Urological Association (EAU) consider TURP a standard treatment for BPH. Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a FREE PDF Sample Report
“Besides analyzing the current market scenario, our report examines historic data from 2017 to 2021”- Technavio
Benign Prostatic Hyperplasia (BPH) Devices Market: Driver & Trend:
Drivers
Increasing prevalence of BPH coupled with increasing risk factors
Emergence of innovative technologies
Rise in demand for laser therapy as an effective alternative to TURP
The increasing prevalence of BPH coupled with increasing risk factors drives the market growth. BPH is one of the most common diseases in aging men with approximately 10% of men in their 30s, 20% of men in their 40s, 50%-60% of men in their 60s, and 80%-90% of men in their 70s and 80s affected by BPH in 2020.
Strategic alliances among market vendors are a key trend in the benign prostatic hyperplasia (BPH) devices market. Identify key trends, drivers, and challenges in the market. Download a FREE sample report to gain access to this information.
Related Reports:
The global ureteroscopy devices market size is estimated to grow by USD 276.91 million at a CAGR of 5.23% between 2022 and 2027.
The medical devices market size is estimated to grow by USD 177.95 billion at a CAGR of 5.87% between 2022 and 2027.
What are the key data covered in this benign prostatic hyperplasia (BPH) devices market report?
CAGR of the market during the forecast period
Detailed information on factors that will drive the growth of the benign prostatic hyperplasia (BPH) devices market between 2021 and 2026.
Precise estimation of the benign prostatic hyperplasia (BPH) devices market size and its contribution to the market in focus on the parent market
Accurate predictions about upcoming trends and changes in consumer behavior
Growth of the benign prostatic hyperplasia (BPH) market across North America, Europe, Asia, and ROW
A thorough analysis of the market’s competitive landscape and detailed information about vendors
Comprehensive analysis of factors that will challenge the growth of benign prostatic hyperplasia (BPH) devices market vendors.
ToC:
Executive Summary
Market Landscape
Market Sizing
Historic Market Sizes
Five Forces Analysis
Market Segmentation by Therapy
Market Segmentation by Geography
Customer Landscape
Geographic Landscape
Drivers, Challenges, & Trends
Company Landscape
Company Analysis
Appendix
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
